HDAC9 and mature T-cell and NK-cell non-Hodgkin lymphoma: Chidamide is a novel benzamide class of HDAC inhibitor, selectively inhibiting activity of HDAC class I, II, III, and X, which was the first approved orphan drug for PTCL in China [108].